A business in context

ATXI research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001437749-26-026372

  2. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001437749-26-015759

  3. 10-K · Annual report

    Report date 2025-12-31 · 0001437749-26-010359

  4. 8-K · Current report

    Report date 2026-02-18 · 0001104659-26-018582 · Items 1.01,8.01,9.01

  5. 4 · Ownership change

    Report date 2026-01-02 · 0001429260-26-000004

  6. 8-K · Current report

    Report date 2025-12-30 · 0001104659-25-125420 · Items 5.07

  7. DEF 14A · Proxy statement

    Report date 2025-12-30 · 0001437749-25-037023

  8. 8-K · Current report

    Report date 2025-11-14 · 0001437749-25-035624 · Items 5.08,8.01

  9. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001437749-25-034821

  10. 8-K · Current report

    Report date 2025-11-05 · 0001437749-25-034243 · Items 1.01,5.02,8.01,9.01

  11. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001437749-25-026935

  12. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001437749-25-017180

  13. 8-K · Current report

    Report date 2025-04-24 · 0001104659-25-042570 · Items 1.01,1.02,2.01,9.01

  14. 4 · Ownership change

    Report date 2025-03-31 · 0001415889-25-009621

  15. 10-K · Annual report

    Report date 2024-12-31 · 0001437749-25-010196

  16. 8-K · Current report

    Report date 2025-03-17 · 0001104659-25-024505 · Items 3.01

  17. 8-K · Current report

    Report date 2025-03-07 · 0001437749-25-006685 · Items 8.01,9.01

  18. 4 · Ownership change

    Report date 2024-12-02 · 0001104659-24-125093

  19. 8-K · Current report

    Report date 2024-11-26 · 0001104659-24-124081 · Items 3.01

  20. SC 13D/A · Ownership disclosure

    0001104659-24-119704

  21. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001437749-24-035309

  22. 8-K · Current report

    Report date 2024-11-14 · 0001437749-24-035304 · Items 2.02,9.01

  23. SC 13G · Ownership disclosure

    0001172661-24-005071

  24. 4 · Ownership change

    Report date 2024-11-05 · 0001104659-24-115424

  25. 4 · Ownership change

    Report date 2024-09-27 · 0001104659-24-104931

  26. 8-K · Current report

    Report date 2024-09-23 · 0001437749-24-030185 · Items 5.02,9.01

  27. 4 · Ownership change

    Report date 2024-09-23 · 0001104659-24-102840

  28. 4 · Ownership change

    Report date 2024-09-23 · 0001104659-24-102839

  29. 4 · Ownership change

    Report date 2024-09-23 · 0001104659-24-102837

  30. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001437749-24-025880

  31. 8-K · Current report

    Report date 2024-08-09 · 0001437749-24-025872 · Items 2.02,9.01

  32. 8-K · Current report

    Report date 2024-06-24 · 0001437749-24-021302 · Items 5.02,5.07,9.01

  33. 8-K · Current report

    Report date 2024-05-21 · 0001437749-24-018072 · Items 8.01

  34. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001437749-24-017062

  35. 8-K · Current report

    Report date 2024-05-15 · 0001437749-24-016818 · Items 2.02,9.01

  36. 8-K · Current report

    Report date 2024-05-10 · 0001437749-24-016081 · Items 1.01,9.01

  37. DEF 14A · Proxy statement

    Report date 2024-06-22 · 0001437749-24-014691

  38. SC 13G/A · Ownership disclosure

    0001079973-24-000641

  39. 8-K · Current report

    Report date 2024-05-01 · 0001437749-24-014178 · Items 1.01,3.02,3.03,8.01,9.01

  40. 8-K · Current report

    Report date 2024-04-25 · 0001437749-24-013436 · Items 3.03,5.03,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001644963AVENUE THERAPEUTICS, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$0$0

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗